Coronavirus (COVID-19)

This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.

This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.

A new issue brief shows where Americans typically get flu vaccines in the U.S. and how much it costs to administer flu and other vaccines. Among the analysis’ findings: while most people get flu vaccines at a doctor’s office or retail health clinic, White people are more likely than Black,…

People with medical conditions that put them at higher risk of developing serious COVID-19 illness are next in line to get vaccinated in many states, though states are making very different choices about how to prioritize those within this large group, finds a KFF analysis of state policies. The U.S.…

During the 55th week since the first coronavirus case appeared in the United States, the world is at nearly 108 million COVID-19 cases. The U.S. approached 27.4 million cases and a total of 475,400 deaths.

Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations. The latest analysis from the KFF COVID-19 Vaccine Monitor highlights how attitudes differ by…

Thirty-one percent of the public wants to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves. While they share a similar level of vaccine hesitancy, this group is not monolithic in their attitudes and beliefs. This brief examines how people with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and may respond differently to messages and information.

In the January report from the COVID-19 Vaccine Monitor, the lack of information around where and when to get the COVID-19 vaccine is particularly pronounced among Hispanic and Black adults compared to White Adults. Learn more in this Chart of the Week.

Throughout the COVID-19 pandemic and resulting economic crisis, about 4 in 10 adults nationwide have reported symptoms of anxiety or depressive disorder – a four-fold increase from pre-pandemic levels. Drawing on the latest national survey data, KFF polling and other research, an updated brief explores what’s known about the pandemic’s…

In his latest Axios column, Drew Altman shows why vaccine hesitancy will naturally decrease as more and more people see their family members and friends vaccinated without adverse consequences. It’s a hopeful sign about vaccine hesitancy, and should help free up resources to focus on the remaining vaccine hesitant.